Johny Bajgai

Dr. Johny Bajgai

yonsei university
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HRHabibur Rahman
Habibur Rahman
JBJohny Bajgai
Johny Bajgai
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
SSSubham Sharma
Subham Sharma
TTThuy Trinh Thi
Thuy Trinh Thi
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Natural products derived from plants, as well as their bioactive compounds, have been extensively studied in recent years for their therapeutic potential in a variety of neurodegenerative diseases (NDs), including Alzheimer’s (AD), Huntington’s (HD), and Parkinson’s (PD) disease. These diseases are characterized by progressive dysfunction and loss of neuronal structure and function. There has been little progress in designing efficient treatments, despite impressive breakthroughs in our understanding of NDs. In the prevention and therapy of NDs, the use of natural products may provide great potential opportunities; however, many clinical issues have emerged regarding their use, primarily based on the lack of scientific support or proof of their effectiveness and patient safety. Since neurodegeneration is associated with a myriad of pathological processes, targeting multi-mechanisms of action and neuroprotection approaches that include preventing cell death and restoring the function of damaged neurons should be employed. In the treatment of NDs, including AD and PD, natural products have emerged as potential neuroprotective agents. This current review will highlight the therapeutic potential of numerous natural products and their bioactive compounds thatexert neuroprotective effects on the pathologies of NDs.

12 December 2018 in Catalysts
Verified
Journal Article
Open access
PDF file
YZYifan Zhang
Yifan Zhang
YHYoung-Jung Heo
Young-Jung Heo
JLJi-Won Lee
Ji-Won Lee
JLJong-Hoon Lee
Jong-Hoon Lee
JBJohny Bajgai
Johny Bajgai
SPSoo-Jin Park
Soo-Jin Park
Photocatalytic H2 generation via water splitting is increasingly gaining attention as a viable alternative for improving the performance of H2 production for solar energy conversion. Many methods were developed to enhance photocatalyst efficiency, primarily by modifying its morphology, crystallization, and electrical properties. Here, we summarize recent achievements in the synthesis and application of various photocatalysts. The rational design of novel photocatalysts was achieved using various strategies, and the applications of novel materials for H2 production are displayed herein. Meanwhile, the challenges and prospects for the future development of H2-producing photocatalysts are also summarized.

6 February 2021 in Processes
Verified
Journal Article
Open access
PDF file
HRHabibur Rahman
Habibur Rahman
JBJohny Bajgai
Johny Bajgai
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
SSSubham Sharma
Subham Sharma
TTThuy Trinh Thi
Thuy Trinh Thi
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Oxidative stress (OS) and neuroinflammatory stress affect many neurological disorders. Despite the clinical significance of oxidative damage in neurological disorders, still, no effective and safe treatment methods for neuro diseases are available. With this, molecular hydrogen (H2) has been recently reported as an antioxidant and anti-inflammatory agent to treat several oxidative stress-related diseases. In animal and human clinical trials, the routes for H2 administration are mainly categorized into three types: H2 gas inhalation, H2 water dissolving, and H2-dissolved saline injection. This review explores some significant progress in research on H2 use in neurodegenerative diseases (NDs), including Alzheimer’s disease, Parkinson’s disease, neonatal disorders of the brain, and other NDs (retinal ischemia and traumatic brain injury). Even though most neurological problems are not currently curable, these studies have shown the therapeutic potential for prevention, treatment, and mitigation of H2 administration. Several possible H2-effectors, including cell signaling molecules and hormones, which prevent OS and inflammation, will also be addressed. However, more clinical and other related studies are required to evaluate the direct H2 target molecule.

18 April 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JAJesmin Ara
Jesmin Ara
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
MAMD FARUK AHMED
MD FARUK AHMED
JBJohny Bajgai
Johny Bajgai
MSMa Easter Joy Villarosa Sajo
Ma Easter Joy Villarosa Sajo
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Purpose. This study was performed to evaluate antifatigue effect of hydrogen water (HW) drinking in chronic forced exercise mice model. Materials and Methods. Twelve-week-old C57BL6 female mice were divided into nonstressed normal control (NC) group and stressed group: (purified water/PW-treated group and HW-treated group). Stressed groups were supplied with PW and HW, respectively, ad libitum and forced to swim for the stress induction every day for 4 consecutive weeks. Gross antifatigue effects of HW were assessed by swimming endurance capacity (once weekly for 4 wk), metabolic activities, and immune-redox activities. Metabolic activities such as blood glucose, lactate, glycogen, blood urea nitrogen (BUN), and lactate dehydrogenase (LDH) as well as immune-redox activities such as reactive oxygen species (ROS), nitric oxide (NO), glutathione peroxidase (GPx), catalase, and the related cytokines were evaluated to elucidate underlying mechanism. Blood glucose and lactate were measured at 0 wk (before swimming) and 4 wk (after swimming). Results. HW group showed a higher swimming endurance capacity (p<0.001) than NC and PW groups. Positive metabolic effects in HW group were revealed by the significant reduction of blood glucose, lactate, and BUN in serum after 4 wk (p<0.01, resp.), as well as the significant increase of liver glycogen (p<0.001) and serum LDH (p<0.05) than PW group. In parallel, redox balance was represented by lower NO in serum (p<0.01) and increased level of GPx in both serum and liver (p<0.05) than PW group. In line, the decreased levels of serum TNF-α (p<0.01), IL-6, IL-17, and liver IL-1β (p<0.05) in HW group revealed positive cytokine profile compared to PW and NC group. Conclusion. This study shows antifatigue effects of HW drinking in chronic forced swimming mice via metabolic coordination and immune-redox balance. In that context, drinking HW could be applied to the alternative and safety fluid remedy for chronic fatigue control.

13 October 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JBJohny Bajgai
Johny Bajgai
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
JAJesmin Ara
Jesmin Ara
Rahima BegumRahima Begum
Rahima Begum
FAFaruk Ahmed
Faruk Ahmed
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Atopic dermatitis (AD) is a chronic relapsing allergic inflammatory skin disease that currently affects millions of children and adults worldwide. Drugs used to treat these inflammatory diseases include anti-histamines, corticosteroids and calcineurin inhibitors but these drugs have their limitations such as adverse effects with their long-term usage. Thus, researcher’s interest in several alternative and complementary therapies are continually growing and balneotherapy is one of these approaches. Therefore, we investigate the bathing effect of high concentration mineral spring water (HMW) on redox balance and immune modulation in 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis like inflammation in hairless mice. We induced AD-like inflammation by application of DNCB on the dorsal skin of female skh-1 hairless mice. The mice were treated with 100% pure HMW (PHMW) and 10% diluted HMW (DHMW) through bathing once a day for 4 weeks. Tacrolimus ointment (0.1%) was used as positive control (PC) and only DNCB treatment as negative control (NeC) group. The severity of skin lesion inflammation was assessed through clinical scoring and observing scratching behavior. Levels of immunoglobulin E (IgE) and inflammatory cytokines in serum were detected by ELISA and multiplex bead array system, and the levels of oxidative stress-related biomarkers and antioxidant enzyme were also measured. We found that HMW significantly decreased the scratching behavior in PHMW and DHMW groups at the 2nd week and in PHMW group at 4th week compared to NeC group. Likewise, serum IgE level was significantly decreased in DHMW group as compared to NeC group. In line, the level of inflammatory cytokines in serum such as interleukin (IL)-1β, IL-13 and tumor necrosis factor-α were significantly inhibited in PHMW and DHMW groups compared to NeC group. In parallel, total reactive oxygen species (ROS) of serum level was significantly decreased in PHMW treatment groups compared to NeC group. Consistently, serum malondialdehyde (MDA) level in PHMW group was lower than in NeC group. By contrast, glutathione peroxidase (GPx) activity was significantly enhanced in PHMW than NeC. Collectively, our study indicates a balneotherapeutic effect of HMW on DNCB-induced AD like inflammation in hairless mice via immunomodulation and redox balance.

Verified
Journal Article
Open access
PDF file
EJEUNSOOK JEONG
EUNSOOK JEONG
JBJohny Bajgai
Johny Bajgai
IYIn-Soo You
In-Soo You
HRHabibur Rahman
Habibur Rahman
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Oxidative stress (OS) is one of the causative factors in the pathogenesis of various neurodegenerative diseases, including Alzheimer’s disease (AD) and cognitive dysfunction. In the present study, we investigated the effects of hydrogen (H2) gas inhalation in trimethyltin (TMT)-induced neurotoxicity and cognitive dysfunction in the C57BL/6 mice. First, mice were divided into the following groups: mice without TMT injection (NC), TMT-only injection group (TMT only), TMT injection + lithium chloride-treated group as a positive control (PC), and TMT injection + 2% H2 inhalation-treated group (H2). The TMT injection groups were administered a single dosage of intraperitoneal TMT injection (2.6 mg/kg body weight) and the H2 group was treated with 2% H2 for 30 min once a day for four weeks. Additionally, a behavioral test was performed with Y-maze to test the cognitive abilities of the mice. Furthermore, multiple OS- and AD-related biomarkers such as reactive oxygen species (ROS), nitric oxide (NO), calcium (Ca2+), malondialdehyde (MDA), glutathione peroxidase (GPx), catalase, inflammatory cytokines, apolipoprotein E (Apo-E), amyloid β (Aβ)-40, phospho-tau (p-tau), Bcl-2, and Bcl-2- associated X (Bax) were investigated in the blood and brain. Our results demonstrated that TMT exposure alters seizure and spatial recognition memory. However, after H2 treatment, memory deficits were ameliorated. H2 treatment also decreased AD-related biomarkers, such as Apo-E, Aβ-40, p-tau, and Bax and OS markers such as ROS, NO, Ca2+, and MDA in both serum and brain. In contrast, catalase and GPx activities were significantly increased in the TMT-only group and decreased after H2 gas treatment in serum and brain. In addition, inflammatory cytokines such as granulocyte colony-stimulating factors (G-CSF), interleukin (IL)-6, and tumor necrosis factor alpha (TNF-α) were found to be significantly decreased after H2 treatment in both serum and brain lysates. In contrast, Bcl-2 and vascular endothelial growth factor (VEGF) expression levels were found to be enhanced after H2 treatment. Taken together, our results demonstrated that 2% H2 gas inhalation in TMT-treated mice exhibits memory enhancing activity and decreases the AD, OS, and inflammatory-related markers. Therefore, H2 might be a candidate for repairing neurodegenerative diseases with cognitive dysfunction. However, further mechanistic studies are needed to fully clarify the effects of H2 inhalation on TMT-induced neurotoxicity and cognitive dysfunction.